NYSE:WST - West Pharmaceutical Services Stock Price, Price Target & More

$88.02 -3.98 (-4.33 %)
(As of 04/25/2018 04:00 PM ET)
Previous Close$92.00
Today's Range$85.60 - $89.00
52-Week Range$80.02 - $103.36
Volume820,787 shs
Average Volume410,376 shs
Market Capitalization$6.81 billion
P/E Ratio33.09
Dividend Yield0.61%
Beta1.11

About West Pharmaceutical Services (NYSE:WST)

West Pharmaceutical Services logoWest Pharmaceutical Services, Inc. manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, and washing and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including CZ, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as specialized testing services for drug packaging, devices, and administration systems. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Receive WST News and Ratings via Email

Sign-up to receive the latest news and ratings for WST and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Fabricated rubber products, not elsewhere classified
Sub-IndustryHealth Care Supplies
SectorMedical
SymbolNYSE:WST
CUSIP95530610
Phone610-594-2900

Debt

Debt-to-Equity Ratio0.15%
Current Ratio2.66%
Quick Ratio1.89%

Price-To-Earnings

Trailing P/E Ratio33.09
Forward P/E Ratio30.99
P/E Growth2.83

Sales & Book Value

Annual Sales$1.60 billion
Price / Sales4.07
Cash Flow$3.9595 per share
Price / Cash22.23
Book Value$17.24 per share
Price / Book5.11

Profitability

EPS (Most Recent Fiscal Year)$2.78
Net Income$150.70 million
Net Margins9.42%
Return on Equity14.68%
Return on Assets9.97%

Miscellaneous

Employees7,500
Outstanding Shares73,990,000

How to Become a New Pot Stock Millionaire

West Pharmaceutical Services (NYSE:WST) Frequently Asked Questions

What is West Pharmaceutical Services' stock symbol?

West Pharmaceutical Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "WST."

How often does West Pharmaceutical Services pay dividends? What is the dividend yield for West Pharmaceutical Services?

West Pharmaceutical Services declared a quarterly dividend on Thursday, February 15th. Shareholders of record on Wednesday, April 18th will be paid a dividend of $0.14 per share on Wednesday, May 2nd. This represents a $0.56 dividend on an annualized basis and a yield of 0.64%. The ex-dividend date of this dividend is Tuesday, April 17th. View West Pharmaceutical Services' Dividend History.

How will West Pharmaceutical Services' stock buyback program work?

West Pharmaceutical Services announced that its board has authorized a share buyback plan on Thursday, February 15th 2018, which allows the company to buyback 800,000 outstanding shares, according to EventVestor. This buyback authorization allows the company to purchase shares of its stock through open market purchases. Shares buyback plans are generally a sign that the company's board of directors believes its shares are undervalued.

How were West Pharmaceutical Services' earnings last quarter?

West Pharmaceutical Services (NYSE:WST) posted its quarterly earnings data on Thursday, February, 15th. The medical instruments supplier reported $0.64 EPS for the quarter, beating the Zacks' consensus estimate of $0.62 by $0.02. The medical instruments supplier earned $415.60 million during the quarter, compared to the consensus estimate of $416.90 million. West Pharmaceutical Services had a net margin of 9.42% and a return on equity of 14.68%. The company's quarterly revenue was up 8.7% on a year-over-year basis. During the same period in the previous year, the company earned $0.54 earnings per share. View West Pharmaceutical Services' Earnings History.

When is West Pharmaceutical Services' next earnings date?

West Pharmaceutical Services is scheduled to release their next quarterly earnings announcement on Thursday, April, 26th 2018. View Earnings Estimates for West Pharmaceutical Services.

What guidance has West Pharmaceutical Services issued on next quarter's earnings?

West Pharmaceutical Services updated its FY18 earnings guidance on Thursday, February, 15th. The company provided earnings per share guidance of $2.80-2.90 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.90. The company issued revenue guidance of $1.72-1.73 billion, compared to the consensus revenue estimate of $1.73 billion.

What price target have analysts set for WST?

5 equities research analysts have issued 1 year target prices for West Pharmaceutical Services' shares. Their predictions range from $85.00 to $115.00. On average, they expect West Pharmaceutical Services' share price to reach $104.20 in the next year. View Analyst Ratings for West Pharmaceutical Services.

Who are some of West Pharmaceutical Services' key competitors?

Who are West Pharmaceutical Services' key executives?

West Pharmaceutical Services' management team includes the folowing people:
  • Mr. Eric M. Green, Chief Exec. Officer, Pres and Director (Age 48)
  • Mr. William J. Federici, Chief Financial Officer, Sr. VP and Treasurer (Age 58)
  • Mr. George Lloyd Miller, Sr. VP, Gen. Counsel and Corp. Sec. (Age 63)
  • Ms. Annette F. Favorite, Chief HR Officer and Sr. VP (Age 53)
  • Ms. Karen A. Flynn, Chief Commercial Officer and Sr. VP (Age 55)

Has West Pharmaceutical Services been receiving favorable news coverage?

Media stories about WST stock have trended somewhat positive recently, according to Accern. The research group identifies positive and negative news coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. West Pharmaceutical Services earned a news impact score of 0.21 on Accern's scale. They also assigned news stories about the medical instruments supplier an impact score of 45.41 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near future.

How do I buy shares of West Pharmaceutical Services?

Shares of WST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is West Pharmaceutical Services' stock price today?

One share of WST stock can currently be purchased for approximately $88.02.

How big of a company is West Pharmaceutical Services?

West Pharmaceutical Services has a market capitalization of $6.81 billion and generates $1.60 billion in revenue each year. The medical instruments supplier earns $150.70 million in net income (profit) each year or $2.78 on an earnings per share basis. West Pharmaceutical Services employs 7,500 workers across the globe.

How can I contact West Pharmaceutical Services?

West Pharmaceutical Services' mailing address is 530 HERMAN O. WEST DRIVE, EXTON PA, 19341. The medical instruments supplier can be reached via phone at 610-594-2900 or via email at [email protected]


MarketBeat Community Rating for West Pharmaceutical Services (WST)

Community Ranking:  1.7 out of 5 (star)
Outperform Votes:  124 (Vote Outperform)
Underperform Votes:  237 (Vote Underperform)
Total Votes:  361
MarketBeat's community ratings are surveys of what our community members think about West Pharmaceutical Services and other stocks. Vote "Outperform" if you believe WST will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WST will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

West Pharmaceutical Services (NYSE:WST) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for West Pharmaceutical Services in the last 12 months. Their average twelve-month price target is $104.20, suggesting that the stock has a possible upside of 18.38%. The high price target for WST is $115.00 and the low price target for WST is $85.00. There are currently 1 sell rating, 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldBuy
Consensus Rating Score: 2.202.402.402.60
Ratings Breakdown: 1 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $104.20$106.80$106.80$106.00
Price Target Upside: 18.38% upside6.40% upside6.40% upside5.02% upside

West Pharmaceutical Services (NYSE:WST) Consensus Price Target History

Price Target History for West Pharmaceutical Services (NYSE:WST)

West Pharmaceutical Services (NYSE:WST) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/25/2018Bank of AmericaDowngradeNeutral -> Underperform$85.00HighView Rating Details
1/24/2018Goldman SachsInitiated CoverageNeutral -> Neutral$110.00LowView Rating Details
10/27/2017Wells FargoBoost Price TargetOutperform$105.00 -> $112.00N/AView Rating Details
10/3/2017StephensInitiated CoverageEqual -> Equal Weight$99.00MediumView Rating Details
9/15/2017Jefferies GroupUpgradeHold -> Buy$96.00 -> $115.00HighView Rating Details
12/23/2016Janney Montgomery ScottReiterated RatingBuyN/AView Rating Details
(Data available from 4/25/2016 forward)

Earnings

West Pharmaceutical Services (NYSE:WST) Earnings History and Estimates Chart

Earnings by Quarter for West Pharmaceutical Services (NYSE:WST)

West Pharmaceutical Services (NYSE:WST) Earnings Estimates

2018 EPS Consensus Estimate: $2.84
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.64$0.64$0.64
Q2 20181$0.70$0.70$0.70
Q3 20181$0.73$0.73$0.73
Q4 20181$0.77$0.77$0.77

West Pharmaceutical Services (NYSE WST) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/25/2018N/AView Earnings Details
2/15/2018Q4 2017$0.62$0.64$416.90 million$415.60 millionViewN/AView Earnings Details
10/26/2017Q3 2017$0.53$0.67$386.02 million$398.20 millionViewN/AView Earnings Details
7/27/2017Q2 2017$0.65$0.6560$406.00 million$397.60 millionViewN/AView Earnings Details
4/27/2017Q1 2017$0.55$0.81$380.42 million$387.70 millionViewN/AView Earnings Details
2/16/2017Q416$0.56$0.54$387.31 million$382.30 millionViewListenView Earnings Details
10/27/2016Q316$0.53$0.53$371.76 million$376.70 millionViewListenView Earnings Details
7/28/2016Q216$0.56$0.59$384.58 million$388.00 millionViewListenView Earnings Details
4/28/2016Q116$0.51$0.53$355.86 million$362.10 millionViewListenView Earnings Details
2/18/2016Q415$0.47$0.47$364.76 million$359.70 millionViewListenView Earnings Details
10/29/2015Q315$0.43$0.44$355.90 million$344.50 millionViewListenView Earnings Details
7/30/2015Q215$0.45$0.47$356.33 million$359.70 millionViewListenView Earnings Details
4/30/2015Q115$0.40$0.45$346.64 million$335.90 millionViewListenView Earnings Details
2/19/2015Q414$0.46$0.45$348.33 million$349.80 millionViewListenView Earnings Details
10/30/2014Q314$0.43$0.44$356.08 million$355.90 millionViewListenView Earnings Details
7/31/2014Q214$0.47$0.52$368.60 million$368.90 millionViewN/AView Earnings Details
5/1/2014Q114$0.41$0.38$340.90 million$346.80 millionViewListenView Earnings Details
2/20/2014Q413$0.38$0.38$348.70 million$342.70 millionViewListenView Earnings Details
10/31/2013Q3 13$0.36$0.39$333.25 million$341.80 millionViewListenView Earnings Details
8/1/2013Q2 2013$0.82$0.86$349.85 million$344.50 millionViewListenView Earnings Details
5/2/2013Q1 2013$0.86$0.87$344.20 million$339.40 millionViewListenView Earnings Details
2/21/2013Q4 2012$0.56$0.61$318.75 million$321.50 millionViewListenView Earnings Details
11/1/2012Q312$0.50$0.52$306.91 million$303.80 millionViewN/AView Earnings Details
8/2/2012$0.69$0.79ViewN/AView Earnings Details
4/26/2012$0.65$0.83ViewN/AView Earnings Details
2/16/2012$0.55$0.59ViewN/AView Earnings Details
11/1/2011$0.54$0.53ViewN/AView Earnings Details
7/28/2011$0.68$0.62ViewN/AView Earnings Details
4/28/2011$0.62$0.60ViewN/AView Earnings Details
2/17/2011$0.46$0.42ViewN/AView Earnings Details
11/2/2010Q3 2010$0.22$0.23ViewN/AView Earnings Details
8/3/2010Q2 2010$0.31$0.32ViewN/AView Earnings Details
4/29/2010Q1 2010$0.26$0.29ViewN/AView Earnings Details
2/18/2010Q4 2009$0.32$0.33ViewN/AView Earnings Details
11/3/2009Q3 2009$0.27$0.23ViewN/AView Earnings Details
8/4/2009Q2 2009$0.27$0.29ViewN/AView Earnings Details
4/30/2009Q1 2009$0.21$0.21ViewN/AView Earnings Details
2/19/2009Q4 2008$0.27$0.28ViewN/AView Earnings Details
11/4/2008Q3 2008$0.24$0.19ViewN/AView Earnings Details
8/5/2008Q2 2008$0.34$0.37ViewN/AView Earnings Details
5/1/2008Q1 2008$0.36$0.36ViewN/AView Earnings Details
2/21/2008Q4 2007$0.24$0.25ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

West Pharmaceutical Services (NYSE:WST) Dividend Information

West Pharmaceutical Services pays an annual dividend of $0.56 per share, with a dividend yield of 0.64%. WST's next quarterly dividend payment will be made on Wednesday, May 2. The company has grown its dividend for the last 25 consecutive years and is increasing its dividend by an average of 8.90% each year. West Pharmaceutical Services pays out 20.14% of its earnings out as a dividend.
Next Dividend:5/2/2018
Annual Dividend:$0.56
Dividend Yield:0.64%
Dividend Growth:8.90% (3 Year Average)
Payout Ratio:20.14% (Trailing 12 Months of Earnings)
19.72% (Based on This Year's Estimates)
17.28% (Based on Next Year's Estimates)
Track Record:25 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for West Pharmaceutical Services (NYSE:WST)

West Pharmaceutical Services (NYSE:WST) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/15/2018Quarterly$0.144/17/20184/18/20185/2/2018
12/22/2017Quarterly$0.140.56%1/17/20181/18/20182/1/2018
7/20/2017Quarterly$0.140.6%10/17/201710/18/201711/1/2017
5/16/2017quarterly$0.130.54%7/17/20177/19/20178/2/2017
2/16/2017Quarterly$0.134/17/20174/19/20175/3/2017
12/14/2016quarterly$0.130.61%1/13/20171/18/20172/1/2017
9/12/2016quarterly$0.1310/17/201610/19/201611/2/2016
7/6/2016Quarterly$0.127/18/20167/20/20168/3/2016
3/4/2016Quarterly$0.124/18/20164/20/20165/4/2016
12/17/2015Quarterly$0.121/15/20161/20/20162/3/2016
7/15/2015quarterly$0.120.79%10/19/201510/21/201511/4/2015
7/2/2015quarterly$0.110.76%7/20/20157/22/20158/5/2015
2/20/2015quarterly$0.110.82%4/20/20154/22/20155/6/2015
12/22/2014quarterly$0.110.81%1/16/20151/21/20152/4/2015
7/16/2014quarterly$0.1110/20/201410/22/201411/5/2014
7/16/2014quarterly$0.111.11%10/15/201410/19/201411/3/2014
5/8/2014quarterly$0.100.94%7/21/20147/23/20148/6/2014
2/20/2014quarterly$0.100.83%4/21/20144/23/20145/7/2014
12/19/2013quarterly$0.100.81%1/17/20141/22/20142/5/2014
8/1/2013quarterly$0.2010/23/201311/6/2013
5/10/2013quarterly$0.191.16%7/22/20137/24/20138/7/2013
3/15/2013quarterly$0.191.21%4/15/20134/17/20135/1/2013
12/27/2012quarterly$0.191.4%1/18/20131/23/20132/6/2013
(Data available from 1/1/2013 forward)

Insider Trades

West Pharmaceutical Services (NYSE WST) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.70%
Institutional Ownership Percentage: 94.34%
Insider Trading History for West Pharmaceutical Services (NYSE:WST)
Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

West Pharmaceutical Services (NYSE WST) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/8/2017William J FedericiCFOSell21,000$99.01$2,079,210.00190,493View SEC Filing  
5/18/2017William J. FedericiCFOSell54,996$95.45$5,249,368.20View SEC Filing  
5/2/2017Daniel MaloneVPSell4,124$93.31$384,810.44View SEC Filing  
12/8/2016Patrick J. ZennerDirectorBuy332$84.53$28,063.96View SEC Filing  
10/31/2016Paula A. JohnsonDirectorSell2,466$75.87$187,095.42View SEC Filing  
9/6/2016Karen FlynnSVPSell14,581$83.28$1,214,305.6813,513View SEC Filing  
8/23/2016Paula A JohnsonDirectorSell3,042$81.55$248,075.1038,450View SEC Filing  
6/2/2016Daniel MaloneVPSell3,950$74.95$296,052.5030,666View SEC Filing  
5/25/2016Thomas W HofmannDirectorSell2,466$73.57$181,423.6234,506View SEC Filing  
3/1/2016Michael A AndersonVPSell16,414$63.58$1,043,602.1270,507View SEC Filing  
2/29/2016Thomas W HofmannDirectorSell3,042$62.70$190,733.4034,637View SEC Filing  
2/25/2016Heino LennartzInsiderSell5,680$62.47$354,829.6018,304View SEC Filing  
2/24/2016Heino LennartzInsiderSell19,658$59.45$1,168,668.1020,911View SEC Filing  
2/23/2016Paula A. JohnsonDirectorSell7,800$59.39$463,242.00View SEC Filing  
2/22/2016Warwick BedwellInsiderSell16,042$59.52$954,819.8443,623View SEC Filing  
11/25/2015John E. PaproskiinsiderSell17,560$63.41$1,113,479.6070,288View SEC Filing  
11/12/2015Heino LennartzInsiderSell3,500$61.87$216,545.0015,435View SEC Filing  
11/6/2015Michael A AndersonVPSell3,000$62.18$186,540.0061,497View SEC Filing  
11/5/2015Michael A. AndersonVPSell10,000$61.98$619,800.0064,497View SEC Filing  
11/4/2015Daniel MaloneVPSell4,456$61.65$274,712.4022,627View SEC Filing  
8/17/2015William J FedericiCFOSell52,678$59.72$3,145,930.16View SEC Filing  
5/28/2015Heino LennartzInsiderSell9,584$55.00$527,120.00View SEC Filing  
5/22/2015Karen FlynnInsiderSell3,091$55.24$170,746.84View SEC Filing  
5/21/2015Eric Mark GreenCEOBuy18,300$54.89$1,004,487.00View SEC Filing  
5/18/2015Karen FlynnInsiderSell1,909$55.00$104,995.00View SEC Filing  
5/15/2015Donald E Morel JrCEOSell20,000$54.29$1,085,800.00View SEC Filing  
2/27/2015Richard D LuzziVPSell10,000$54.85$548,500.00View SEC Filing  
2/26/2015Michael A AndersonVPSell4,682$54.93$257,182.26View SEC Filing  
2/25/2015Heino LennartzInsiderSell3,617$54.82$198,283.94View SEC Filing  
2/24/2015John E PaproskiInsiderSell9,282$52.87$490,739.34View SEC Filing  
2/23/2015Heino LennartzInsiderSell21,040$53.40$1,123,536.00View SEC Filing  
2/23/2015Patrick J ZennerDirectorSell12,800$53.69$687,232.00View SEC Filing  
11/26/2014Richard D LuzziVPSell8,000$52.11$416,880.00View SEC Filing  
11/21/2014William J FedericiCFOSell3,000$51.22$153,660.00View SEC Filing  
11/20/2014Donald E Morel JrCEOSell20,000$51.30$1,026,000.00View SEC Filing  
11/13/2014John R GaileyVPSell28,000$52.37$1,466,360.00View SEC Filing  
11/11/2014Michael A AndersonVPSell4,600$51.73$237,958.00View SEC Filing  
11/10/2014Warwick BedwellInsiderSell6,306$49.95$314,984.70View SEC Filing  
8/21/2014Richard D LuzziVPSell10,000$44.07$440,700.00View SEC Filing  
8/20/2014John R GaileyVPSell20,000$43.96$879,200.00View SEC Filing  
8/19/2014Michael A AndersonVPSell9,800$43.41$425,418.00View SEC Filing  
8/18/2014William J FedericiCFOSell38,366$42.56$1,632,856.96View SEC Filing  
8/13/2014Heino LennartzInsiderSell7,555$39.65$299,555.75View SEC Filing  
8/11/2014Heino LennartzInsiderSell11,445$40.00$457,800.00View SEC Filing  
8/7/2014John E PaproskiInsiderSell14,000$40.44$566,160.00View SEC Filing  
5/30/2014Richard D LuzziVPSell22,828$42.17$962,656.76View SEC Filing  
5/29/2014Heino LennartzInsiderSell2,000$43.00$86,000.00View SEC Filing  
2/28/2014Heino LennartzInsiderSell16,044$45.84$735,456.96View SEC Filing  
2/26/2014Patrick J ZennerDirectorSell12,800$46.12$590,336.00View SEC Filing  
2/24/2014Warwick BedwellInsiderSell24,606$47.49$1,168,538.94View SEC Filing  
11/26/2013Donald E Morel JrCEOSell35,000$48.60$1,701,000.00View SEC Filing  
11/22/2013William J FedericiCFOSell36,000$48.34$1,740,240.00View SEC Filing  
11/19/2013Karen FlynnInsiderSell5,500$47.75$262,625.00View SEC Filing  
11/8/2013Michael A AndersonVPSell9,200$46.80$430,560.00View SEC Filing  
11/7/2013Heino LennartzInsiderSell5,102$46.70$238,263.40View SEC Filing  
11/6/2013Michael A AndersonVPSell6,000$46.53$279,180.00View SEC Filing  
11/5/2013John R GaileyVPSell6,000$46.83$280,980.00View SEC Filing  
11/5/2013Warwick BedwellInsiderSell6,304$46.84$295,279.36View SEC Filing  
11/4/2013Richard D LuzziVPSell38,708$46.99$1,818,888.92View SEC Filing  
8/30/2013Donald E Morel JrCEOSell10,000$74.46$744,600.00View SEC Filing  
8/27/2013John R GaileyVPSell13,749$76.77$1,055,510.73View SEC Filing  
8/22/2013L Robert JohnsonDirectorSell1,883$76.81$144,633.23View SEC Filing  
8/14/2013John E PaproskiInsiderSell6,011$79.08$475,349.88View SEC Filing  
8/12/2013Anthony WeltersDirectorSell19,200$78.43$1,505,856.00View SEC Filing  
8/8/2013Michael A AndersonVPSell4,300$78.00$335,400.00View SEC Filing  
5/31/2013Michael A AndersonVPSell4,000$68.94$275,760.00View SEC Filing  
5/28/2013Donald E Morel JrCEOSell10,000$67.87$678,700.00View SEC Filing  
5/24/2013L Robert JohnsonDirectorSell1,700$67.47$114,699.00View SEC Filing  
5/20/2013John R GaileyVPSell9,282$68.54$636,188.28View SEC Filing  
5/17/2013L Robert JohnsonDirectorSell4,000$67.80$271,200.00View SEC Filing  
5/8/2013L Robert JohnsonDirectorSell6,400$64.49$412,736.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

West Pharmaceutical Services (NYSE WST) News Headlines

Source:
DateHeadline
West Pharmaceutical Services (WST) Stock Rating Lowered by Bank of AmericaWest Pharmaceutical Services (WST) Stock Rating Lowered by Bank of America
www.americanbankingnews.com - April 25 at 10:14 AM
BofA/Merrill Lynch Downgrades West Pharmaceutical (WST) to UnderperformBofA/Merrill Lynch Downgrades West Pharmaceutical (WST) to Underperform
www.streetinsider.com - April 25 at 9:36 AM
Contrasting West Pharmaceutical Services (WST) & Carlisle Companies (CSL)Contrasting West Pharmaceutical Services (WST) & Carlisle Companies (CSL)
www.americanbankingnews.com - April 23 at 5:08 PM
West Pharmaceutical Services (WST) Given Consensus Rating of "Hold" by AnalystsWest Pharmaceutical Services (WST) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - April 21 at 3:48 AM
West Pharmaceutical Services (WST) & Female Health (VERU) Head to Head SurveyWest Pharmaceutical Services (WST) & Female Health (VERU) Head to Head Survey
www.americanbankingnews.com - April 19 at 1:22 AM
Zacks: Analysts Expect West Pharmaceutical Services (WST) Will Post Quarterly Sales of $407.45 MillionZacks: Analysts Expect West Pharmaceutical Services (WST) Will Post Quarterly Sales of $407.45 Million
www.americanbankingnews.com - April 18 at 4:48 AM
West Pharmaceutical Services (WST) to Release Quarterly Earnings on WednesdayWest Pharmaceutical Services (WST) to Release Quarterly Earnings on Wednesday
www.americanbankingnews.com - April 18 at 4:02 AM
EX-Dividend Schedule: Has Raised Dividend for 25 Consecutive Years; Will Trade Ex-Dividend on April 17, 2018EX-Dividend Schedule: Has Raised Dividend for 25 Consecutive Years; Will Trade Ex-Dividend on April 17, 2018
finance.yahoo.com - April 16 at 9:24 AM
West Pharmaceutical Services (WST) Expected to Announce Earnings of $0.65 Per ShareWest Pharmaceutical Services (WST) Expected to Announce Earnings of $0.65 Per Share
www.americanbankingnews.com - April 16 at 3:24 AM
Ex-Div Reminder for West Pharmaceutical Services (WST)Ex-Div Reminder for West Pharmaceutical Services (WST)
www.nasdaq.com - April 13 at 4:28 PM
West to Host First-Quarter 2018 Conference CallWest to Host First-Quarter 2018 Conference Call
finance.yahoo.com - April 12 at 10:23 AM
Contrasting West Pharmaceutical Services (WST) and Female Health (VERU)Contrasting West Pharmaceutical Services (WST) and Female Health (VERU)
www.americanbankingnews.com - April 8 at 11:24 AM
West Pharmaceutical Services (WST) Cut to "Sell" at ValuEngineWest Pharmaceutical Services (WST) Cut to "Sell" at ValuEngine
www.americanbankingnews.com - April 7 at 7:02 AM
West Pharmaceutical Services (WST) Rating Lowered to Neutral at Bank of AmericaWest Pharmaceutical Services (WST) Rating Lowered to Neutral at Bank of America
www.americanbankingnews.com - April 6 at 11:32 PM
Female Health (VERU) vs. West Pharmaceutical Services (WST) Critical ComparisonFemale Health (VERU) vs. West Pharmaceutical Services (WST) Critical Comparison
www.americanbankingnews.com - April 6 at 1:18 PM
West Pharmaceutical Services Inc. (WST) Expected to Post Quarterly Sales of $409.97 MillionWest Pharmaceutical Services Inc. (WST) Expected to Post Quarterly Sales of $409.97 Million
www.americanbankingnews.com - April 1 at 4:54 AM
 Brokerages Expect West Pharmaceutical Services Inc. (WST) to Post $0.66 Earnings Per Share Brokerages Expect West Pharmaceutical Services Inc. (WST) to Post $0.66 Earnings Per Share
www.americanbankingnews.com - March 30 at 5:17 AM
West Pharmaceutical Services Inc. (WST) Given Average Recommendation of "Hold" by AnalystsWest Pharmaceutical Services Inc. (WST) Given Average Recommendation of "Hold" by Analysts
www.americanbankingnews.com - March 27 at 3:25 AM
Edited Transcript of WST earnings conference call or presentation 15-Feb-18 2:00pm GMTEdited Transcript of WST earnings conference call or presentation 15-Feb-18 2:00pm GMT
finance.yahoo.com - March 18 at 9:25 AM
Short Interest in West Pharmaceutical Services Inc. (WST) Rises By 56.9%Short Interest in West Pharmaceutical Services Inc. (WST) Rises By 56.9%
www.americanbankingnews.com - March 16 at 1:56 AM
Gamida Cell Appoints Shai Lankry as Chief Financial OfficerGamida Cell Appoints Shai Lankry as Chief Financial Officer
www.bizjournals.com - March 15 at 4:54 PM
 Analysts Anticipate West Pharmaceutical Services Inc. (WST) Will Post Quarterly Sales of $409.97 Million Analysts Anticipate West Pharmaceutical Services Inc. (WST) Will Post Quarterly Sales of $409.97 Million
www.americanbankingnews.com - March 15 at 1:37 PM
$0.66 Earnings Per Share Expected for West Pharmaceutical Services Inc. (WST) This Quarter$0.66 Earnings Per Share Expected for West Pharmaceutical Services Inc. (WST) This Quarter
www.americanbankingnews.com - March 13 at 3:18 AM
Brokers Offer Predictions for West Pharmaceutical Services Inc.s Q1 2018 Earnings (WST)Brokers Offer Predictions for West Pharmaceutical Services Inc.'s Q1 2018 Earnings (WST)
www.americanbankingnews.com - March 12 at 1:17 AM
Is West Pharmaceutical Services Inc (NYSE:WST) A Sell At Its Current PE Ratio?Is West Pharmaceutical Services Inc (NYSE:WST) A Sell At Its Current PE Ratio?
finance.yahoo.com - March 9 at 5:26 PM
WINTON GROUP Ltd Buys New Stake in West Pharmaceutical Services Inc. (WST)WINTON GROUP Ltd Buys New Stake in West Pharmaceutical Services Inc. (WST)
www.americanbankingnews.com - March 6 at 3:38 PM
West Pharmaceutical Services Inc. (WST) Stake Increased by Koch Industries Inc.West Pharmaceutical Services Inc. (WST) Stake Increased by Koch Industries Inc.
www.americanbankingnews.com - March 6 at 2:03 PM
West Pharmaceutical Services Inc. (WST) Position Increased by Alliancebernstein L.P.West Pharmaceutical Services Inc. (WST) Position Increased by Alliancebernstein L.P.
www.americanbankingnews.com - March 6 at 4:14 AM
West Pharmaceutical Services Inc. (WST) Shares Sold by Lombard Odier Asset Management Switzerland SAWest Pharmaceutical Services Inc. (WST) Shares Sold by Lombard Odier Asset Management Switzerland SA
www.americanbankingnews.com - March 4 at 2:39 PM
State of Tennessee Treasury Department Sells 40,000 Shares of West Pharmaceutical Services Inc. (WST)State of Tennessee Treasury Department Sells 40,000 Shares of West Pharmaceutical Services Inc. (WST)
www.americanbankingnews.com - March 4 at 11:46 AM
Bank of New York Mellon Corp Has $85.22 Million Holdings in West Pharmaceutical Services Inc. (WST)Bank of New York Mellon Corp Has $85.22 Million Holdings in West Pharmaceutical Services Inc. (WST)
www.americanbankingnews.com - March 3 at 4:43 AM
BRIEF-West Chief Financial Officer William Federici Announces Plans To RetireBRIEF-West Chief Financial Officer William Federici Announces Plans To Retire
www.reuters.com - March 2 at 9:23 AM
William Federici announces plans to retireWilliam Federici announces plans to retire
seekingalpha.com - March 2 at 9:23 AM
First Trust Advisors LP Trims Stake in West Pharmaceutical Services Inc. (WST)First Trust Advisors LP Trims Stake in West Pharmaceutical Services Inc. (WST)
www.americanbankingnews.com - March 2 at 8:18 AM
West Pharmaceutical Services Inc. (WST) Given Average Rating of "Hold" by BrokeragesWest Pharmaceutical Services Inc. (WST) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - March 2 at 3:36 AM
The Manufacturers Life Insurance Company  Has $12.16 Million Stake in West Pharmaceutical Services Inc. (WST)The Manufacturers Life Insurance Company Has $12.16 Million Stake in West Pharmaceutical Services Inc. (WST)
www.americanbankingnews.com - March 1 at 6:04 PM
West Pharmaceutical Services Inc (WST) Files 10-K for the Fiscal Year Ended on December 31, 2017West Pharmaceutical Services Inc (WST) Files 10-K for the Fiscal Year Ended on December 31, 2017
finance.yahoo.com - February 27 at 9:31 AM
Carillon Tower Advisers Inc. Invests $39.04 Million in West Pharmaceutical Services Inc. (WST) StockCarillon Tower Advisers Inc. Invests $39.04 Million in West Pharmaceutical Services Inc. (WST) Stock
www.americanbankingnews.com - February 27 at 5:28 AM
West Pharmaceutical Services Inc. (WST) Shares Bought by BlackRock Inc.West Pharmaceutical Services Inc. (WST) Shares Bought by BlackRock Inc.
www.americanbankingnews.com - February 27 at 4:57 AM
Rhumbline Advisers Has $17.01 Million Position in West Pharmaceutical Services Inc. (WST)Rhumbline Advisers Has $17.01 Million Position in West Pharmaceutical Services Inc. (WST)
www.americanbankingnews.com - February 26 at 1:42 PM
West Pharmaceutical Services Inc. (WST) Expected to Post Quarterly Sales of $412.97 MillionWest Pharmaceutical Services Inc. (WST) Expected to Post Quarterly Sales of $412.97 Million
www.americanbankingnews.com - February 26 at 10:18 AM
West Pharmaceutical Services Inc. (WST) Holdings Trimmed by Wells Fargo & Company MNWest Pharmaceutical Services Inc. (WST) Holdings Trimmed by Wells Fargo & Company MN
www.americanbankingnews.com - February 26 at 10:10 AM
Brown Advisory Inc. Buys 124,227 Shares of West Pharmaceutical Services Inc. (WST)Brown Advisory Inc. Buys 124,227 Shares of West Pharmaceutical Services Inc. (WST)
www.americanbankingnews.com - February 26 at 4:52 AM
West Pharmaceutical Services Inc. (WST) Shares Sold by Employees Retirement System of TexasWest Pharmaceutical Services Inc. (WST) Shares Sold by Employees Retirement System of Texas
www.americanbankingnews.com - February 25 at 5:26 AM
Eaton Vance Management Cuts Stake in West Pharmaceutical Services Inc. (WST)Eaton Vance Management Cuts Stake in West Pharmaceutical Services Inc. (WST)
www.americanbankingnews.com - February 25 at 5:20 AM
Citadel Advisors LLC Has $3.23 Million Position in West Pharmaceutical Services Inc. (WST)Citadel Advisors LLC Has $3.23 Million Position in West Pharmaceutical Services Inc. (WST)
www.americanbankingnews.com - February 25 at 4:56 AM
Arizona State Retirement System Has $5.27 Million Holdings in West Pharmaceutical Services Inc. (WST)Arizona State Retirement System Has $5.27 Million Holdings in West Pharmaceutical Services Inc. (WST)
www.americanbankingnews.com - February 25 at 4:16 AM
West Pharmaceutical (WST) Presents At RBC Capital Markets Global Healthcare Conference - SlideshowWest Pharmaceutical (WST) Presents At RBC Capital Markets Global Healthcare Conference - Slideshow
seekingalpha.com - February 24 at 9:16 AM
California Public Employees Retirement System Acquires 4,713 Shares of West Pharmaceutical Services Inc. (WST)California Public Employees Retirement System Acquires 4,713 Shares of West Pharmaceutical Services Inc. (WST)
www.americanbankingnews.com - February 24 at 5:10 AM
Q1 2018 EPS Estimates for West Pharmaceutical Services Inc. (WST) Lowered by Jefferies GroupQ1 2018 EPS Estimates for West Pharmaceutical Services Inc. (WST) Lowered by Jefferies Group
www.americanbankingnews.com - February 19 at 1:24 AM

SEC Filings

West Pharmaceutical Services (NYSE:WST) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

West Pharmaceutical Services (NYSE:WST) Income Statement, Balance Sheet and Cash Flow Statement

Chart

West Pharmaceutical Services (NYSE WST) Stock Chart for Wednesday, April, 25, 2018

Loading chart…

This page was last updated on 4/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.